Guidance for Elderly With Cognitive Disorders (BOCS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT01076855
First received: February 25, 2010
Last updated: February 1, 2013
Last verified: February 2013
  Purpose

The purpose of the programme is to facilitate the anticipation of dementia both in elderly patients suffering from this disease and in their carers and to diminish care burden in order to improve quality of life and daily functioning.


Condition
Mild Dementia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Guidance Programme for Elderly With Cognitive Disorders

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Quality of life and care burden at 0, 3 and 6 months. [ Time Frame: 0, 3 and 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Cognitive, behavioural and affective status [ Time Frame: 0, 3 and 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: January 2010
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Elderly with mild dementia
>70 years old and presence of a carer

  Eligibility

Ages Eligible for Study:   70 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

elderly (>70 years) with mild dementia in presence of a carer.

Criteria

Inclusion Criteria:

  • elderly (> 70 years) with mild dementia in presence of a carer.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01076855

Contacts
Contact: Mirko Petrovic, MD, PhD mirko.petrovic@ugent.be
Contact: Carine Sachem carine.sachem@uzgent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium
Contact: Mirko Petrovic, MD, PhD       mirko.petrovic@ugent.be   
Principal Investigator: Mirko Petrovic, MD, PhD         
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Mirko Petrovic, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT01076855     History of Changes
Other Study ID Numbers: 2010/008
Study First Received: February 25, 2010
Last Updated: February 1, 2013
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Cognition Disorders
Dementia
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on July 29, 2014